In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function
March 27th 2025The prevalence of tobacco use in schizophrenia is over 60%—3 times that of the general population. However, the reason for the high prevalence of tobacco use in schizophrenia remains largely unknown.
When the Fog Doesn’t Lift: Targeting Cognitive Dysfunction in Depression
March 24th 2025Cognitive symptoms affect between 85% and 94% of patients with major depressive disorder. Despite this prevalence, cognitive dysfunction often remains undertreated and inadequately addressed in routine clinical practice.